Identification of disease-associated genetic changes in breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2, not only has actionable implications for carriers, but also for the additional members of their family who are found to carry the high-risk variant. This evidence concerns the gene BRCA2 and breast carcinoma.